What is Medifast's EBITDA?

Medifast (MED) reported EBITDA of $188K in Q1 2026.

How has Medifast's EBITDA changed year-over-year?

Medifast's EBITDA decreased by 90.7% year-over-year, from $2.02M to $188K.

What is the long-term trend for Medifast's EBITDA?

Over 4 years (2021 to 2025), Medifast's EBITDA has grown at a -89.2% compound annual growth rate (CAGR), from $223.05M to $30K.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Medifast MED EBITDA

EBITDA at other companies

WW International, Inc.WW

-$4.55M+65.7%

HerbalifeHLF

$167.8M+9.3%

Omada Health, Inc. Common StockOMDA

-$3.27M+53.7%

Lifevantage CorporationLFVN

$2.39M-50.7%

Eli LillyLLY

——

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Calculated from Medifast’s reported figures.

−$3.3Mebit+

$3.5MDepreciation Depletion & Amortization

=$188K

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's EBITDA?: Medifast (MED) reported EBITDA of $188K in Q1 2026.
How has Medifast's EBITDA changed year-over-year?: Medifast's EBITDA decreased by 90.7% year-over-year, from $2.02M to $188K.
What is the long-term trend for Medifast's EBITDA?: Over 4 years (2021 to 2025), Medifast's EBITDA has grown at a -89.2% compound annual growth rate (CAGR), from $223.05M to $30K.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.